Office of Medical Communications

As the US begins to see demand for COVID-19 vaccines plateau, some states have started implementing incentive programs to encourage residents to get one of the three vaccines available: Pfizer, Moderna, or Johnson & Johnson. Recently announced incentive programs are supported by numerous research studies that support the efficacy of incentivizing vaccine adherence.

In a salute to graduating medical students’ accomplishments and to honor the faculty and staff who have supported them during their medical education journey, the University of Vermont Larner College of Medicine launched a virtual 2021 Honors Celebration on May 6, 2021.

In this presentation, Dr. Harder shares results from a baseline needs assessment survey with practitioners across Vermont and New Hampshire related to substance use and treatment. Learn about the level of concern that practitioners have for many substances including opioids, stimulants, cannabis, and tobacco, and about their beliefs related to treatment. Learn about the barriers that practitioners and patients face in relation to providing and seeking treatment for opioid use disorder, how comfortable practitioners feel treating opioid use disorder, and how comfort and barriers are related.

In light of the concerns voiced by students across campus over the past week regarding the University's sexual assault prevention, reporting and survivor support services, we wish to underscore the University’s clear position that sexual harassment, sexual assault, gender-based stalking, relationship violence, and all other forms of sexual misconduct are prohibited at UVM and at the Larner College of Medicine.

In recognition of the second anniversary of the formal introduction and celebration of the Larner College of Medicine's Statement on Professionalism, the College hosted its first Professionalism Week from Monday, May 3 through Friday, May 7, 2021.

Senior Associate Dean for Medical Education Christa Zehle, M.D., has been appointed University of Vermont Health Network Director of Education by John Brumsted, M.D., CEO of the UVM Health Network.

UVM Assistant Professor of Surgery Christopher Brady, M.D., considers Vermont the “perfect living laboratory” for experimenting with telehealth. Even before the COVID-19 pandemic prompted a massive shift in healthcare delivery, he’s been researching how to efficiently provide preventive care to the patients who need it the most.

2021 Burton E. Sobel Visiting Professor: Judith S. Hochman, MD joins the Cardiovascular Research Institute of Vermont for career development seminar and Medicine Grand Rounds program "The Role of Revascularization in SIHD: A Deep Dive into ISCHEMIA".

​Assessing gene expression with morphological context is critical to our understanding of biology and the progression of disease. Learn how Visium Spatial Solutions from 10x Genomics are enabling researchers to map the whole transcriptome with morphological context. Learn how Visium Spatial Solutions can enable uncovering novel insights into normal development, disease pathology, and clinical translational research.

The University of Vermont Graduate College has announced that Beth Kirkpatrick, M.D., professor and chair of microbiology and molecular genetics, has been named one or three 2021-2022 University Scholars. The University Scholars program recognizes distinguished UVM faculty members for sustained excellence in research, scholarship, and creative arts.

(APRIL 15, 2021) Assistant Professor of Psychiatry Jeremiah Dickerson, M.D., was interviewed by local Burlington, Vt. CBS affiliate WCAX-TV for a story, titled "Should parents worry about pandemic’s long-term effects on kids?"

In the summer of 2020, a commentary in Pediatrics by William Raszka, M.D., and Ben Lee, M.D., led to a flurry of interest around the globe. The duo of pediatric infectious disease experts found that “children are not significant drivers of the COVID-19 pandemic” based on an analysis of early studies from Switzerland, China, France and Australia. They wrote: “On the basis of these data, SARS-CoV-2 transmission in schools may be less important in community transmission than initially feared.”

(APRIL 13, 2021) Mary Cushman, M.D., M.Sc., professor of medicine and co-principal investigator of the Vermont Center on Cardiovascular and Brain Health, commented on the risk of blood clots in young women in relation to COVID-19 vaccination status in a Business Insider article, titled "Why younger women have a higher risk of blood clots, whether or not they're vaccinated."

Randall F. Holcombe, M.D., M.B.A., has been appointed director of the UVM Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. Holcombe will officially begin his tenure August 1, 2021.

On March 18, 2021, researchers from across UVM came together via Zoom for the second edition of the Translational Global Infectious Diseases Research Center's COVID-19 research slam, titled “UVM Tackles COVID-19: Research Progress and Perspectives One Year into the Pandemic.”